Athira Pharma Statistics

Total Valuation

Athira Pharma has a market cap or net worth of $10.58 million. The enterprise value is -$38.58 million.

Market Cap	10.58M
Enterprise Value	-38.58M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Athira Pharma has 39.04 million shares outstanding. The number of shares has increased by 1.21% in one year.

Current Share Class	39.04M
Shares Outstanding	39.04M
Shares Change (YoY)	+1.21%
Shares Change (QoQ)	+0.48%
Owned by Insiders (%)	13.57%
Owned by Institutions (%)	21.43%
Float	25.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.26
P/TBV Ratio	0.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.03.

Current Ratio	4.18
Quick Ratio	3.90
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -110.77% and return on invested capital (ROIC) is -68.02%.

Return on Equity (ROE)	-110.77%
Return on Assets (ROA)	-55.23%
Return on Invested Capital (ROIC)	-68.02%
Return on Capital Employed (ROCE)	-212.02%
Revenue Per Employee	n/a
Profits Per Employee	-$3.73M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.89% in the last 52 weeks. The beta is 3.05, so Athira Pharma's price volatility has been higher than the market average.

Beta (5Y)	3.05
52-Week Price Change	-85.89%
50-Day Moving Average	0.33
200-Day Moving Average	0.99
Relative Strength Index (RSI)	52.28
Average Volume (20 Days)	224,264

Short Selling Information

The latest short interest is 826,618, so 2.12% of the outstanding shares have been sold short.

Short Interest	826,618
Short Previous Month	934,467
Short % of Shares Out	2.12%
Short % of Float	3.23%
Short Ratio (days to cover)	4.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-96.78M
Pretax Income	-113.45M
Net Income	-96.94M
EBITDA	-95.81M
EBIT	-96.78M
Earnings Per Share (EPS)	-$2.52

Full Income Statement

Balance Sheet

The company has $51.28 million in cash and $1.22 million in debt, giving a net cash position of $50.06 million or $1.28 per share.

Cash & Cash Equivalents	51.28M
Total Debt	1.22M
Net Cash	50.06M
Net Cash Per Share	$1.28
Equity (Book Value)	44.84M
Book Value Per Share	1.15
Working Capital	41.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$97.17 million and capital expenditures -$33,000, giving a free cash flow of -$97.20 million.

Operating Cash Flow	-97.17M
Capital Expenditures	-33,000
Free Cash Flow	-97.20M
FCF Per Share	-$2.49

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Athira Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.21%
Shareholder Yield	-1.21%
Earnings Yield	-844.54%
FCF Yield	-846.83%

Analyst Forecast

The average price target for Athira Pharma is $11.25, which is 4,051.29% higher than the current price. The consensus rating is "Buy".

Price Target	$11.25
Price Target Difference	4,051.29%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a